アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

c.b. fleet company, inc. - docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag) - stool softener - for prevention of dry, hard stools - for relief of occasional constipation - this product usually produces a bowel movement in 12 to 72 hours

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bryant ranch prepack - clindamycin palmitate hydrochloride (unii: vn9a8jm7m7) (clindamycin - unii:3u02el437c) - clindamycin palmitate hydrochloride for oral solution, usp (pediatric) (clindamycin palmitate hcl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection. streptococci: serious respiratory tract infections; serious skin and soft tissue infections. staphylococci: serious respiratory tract infections; serious skin and soft tissue infections. pneumococci: serious respiratory tract infections. bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin palmitate hydrochloride for oral solution (pediatric) and other antibacterial drugs, clindamycin palmitate hydrochloride for oral solution (pediatric) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - diphtheria toxoid adsorbed tetanus toxoid adsorbed pertussis toxoid adsorbed (pt) filamentous haemagglutinin adsorbed (fha) fimbriae types 2 and 3 adsorbed (fim) pertactin adsorbed (prn) inactivated poliomyelitis vaccine type 1 (mahoney) inactivated poliomyelitis vaccine type 2 (mef-1) inactivated poliomyelitis vaccine type 3 (saukett) haemophilus influenzae b conjugate vaccine (prp-t) conjugated to tenanus protein aluminium phosphate (a1) - suspension for injection

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - diphtheria toxoid adsorbed tetanus toxoid adsorbed pertussis toxoid adsorbed (pt) filamentous haemagglutinin adsorbed (fha) fimbriae types 2 and 3 adsorbed (fim) pertactin adsorbed (prn) inactivated poliomyelitis vaccine type 1 (mahoney) inactivated poliomyelitis vaccine type 2 (mef-1) inactivated poliomyelitis vaccine type 3 (saukett) haemophilus influenzae b conjugate vaccine (prp-t) conjugated to tenanus protein aluminium phosphate (a1) - suspension for injection

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,biotin,cyanocobalamin,ferrous fumarate,folic acid -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,biotin,cyanocobalamin,ferrous fumarate,folic acid -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,calcium hydrogen phosphate dihydrate,calcium pantothenate,colecalciferol,dolomite,retinol palmitate,zinc amino acid chelate -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,zinc amino acid chelate -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 34893 - cannula, arterial - pediatric arterial cannulae used in cardiopulmonary bypass surgery. intended for use in perfusion of the ascending aorta during cardiopulmonary bypass.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 45966 - pacing lead, external, transthoracic, temporary - temporary pacing lead intended for temporary atrial and ventricular pacing and sensing for a contemplated implant duration of 7 days or less.